These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 9803422)

  • 21. Effects of moxonidine and clonidine on renal function and blood pressure in anesthetized rats.
    Hohage H; Schlatter E; Greven J
    Clin Nephrol; 1997 May; 47(5):316-24. PubMed ID: 9181279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cerebrospinal fluid markers for Alzheimer's disease over the lifespan: effects of age and the APOEε4 genotype.
    Popp J; Lewczuk P; Frommann I; Kölsch H; Kornhuber J; Maier W; Jessen F
    J Alzheimers Dis; 2010; 22(2):459-68. PubMed ID: 21084733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased levels of neuronal thread protein in cerebrospinal fluid of patients with Alzheimer's disease.
    de la Monte SM; Volicer L; Hauser SL; Wands JR
    Ann Neurol; 1992 Dec; 32(6):733-42. PubMed ID: 1471863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased plasma and cerebrospinal fluid norepinephrine in older men: differential suppression by clonidine.
    Raskind MA; Peskind ER; Veith RC; Beard JC; Gumbrecht G; Halter JB
    J Clin Endocrinol Metab; 1988 Feb; 66(2):438-43. PubMed ID: 3339115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Yohimbine increases cerebrospinal fluid and plasma norepinephrine but not arginine vasopressin in humans.
    Peskind ER; Veith RC; Dorsa DM; Gumbrecht G; Raskind MA
    Neuroendocrinology; 1989 Sep; 50(3):286-91. PubMed ID: 2552342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exacerbated CSF abnormalities in younger patients with Alzheimer's disease.
    Dumurgier J; Gabelle A; Vercruysse O; Bombois S; Laplanche JL; Peoc'h K; Schraen S; Sablonnière B; Pasquier F; Touchon J; Lehmann S; Hugon J; Paquet C
    Neurobiol Dis; 2013 Jun; 54():486-91. PubMed ID: 23416172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of alpha- and beta-adrenergic agonists and antagonists on growth hormone secretion in man.
    Mazza E; Ghigo E; Bellone J; Arvat E; Revelli E; Cella SG; Brambilla F; Müller EE; Camanni F
    Endocrinol Exp; 1990 Mar; 24(1-2):211-9. PubMed ID: 1972919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of adrenergic alpha-2-receptors on feeding behavior in layer-type chicks.
    Tachibana T; Sugahara K; Ueda H; Cline MA
    Gen Comp Endocrinol; 2009 May; 161(3):407-11. PubMed ID: 19233186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alpha-2 adrenergic modulation of prefrontal cortical neuronal activity related to spatial working memory in monkeys.
    Li BM; Mao ZM; Wang M; Mei ZT
    Neuropsychopharmacology; 1999 Nov; 21(5):601-10. PubMed ID: 10516956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electrogenic and electroneutral components of the sympathetic effect on fluid absorption in the rat jejunum.
    Hemlin M; Butcher P; Sjövall H
    Acta Physiol Scand; 1987 Dec; 131(4):599-608. PubMed ID: 2894743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebrospinal fluid C3a increases with age, but does not increase further in Alzheimer's disease.
    Loeffler DA; Brickman CM; Juneau PL; Perry MF; Pomara N; Lewitt PA
    Neurobiol Aging; 1997; 18(5):555-7. PubMed ID: 9390784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aging and Alzheimer's disease: protease inhibitors in cerebrospinal fluid.
    Delamarche C; Berger F; Gallard L; Pouplard-Barthelaix A
    Neurobiol Aging; 1991; 12(1):71-4. PubMed ID: 2002886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clonidine impairs sustained attention and memory in Alzheimer's disease.
    Riekkinen M; Laakso MP; Jäkälä P
    Neuroscience; 1999; 92(3):975-82. PubMed ID: 10426537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [EFFECTS OF 3-EPI-ISOYOHIMBINE OR (3-EPI-ALPHA-YOHIMBINE) ON THE SYMPATHETIC NERVOUS SYSTEM].
    RAYMOND-HAMET
    C R Hebd Seances Acad Sci; 1964 Jan; 258():372-4. PubMed ID: 14132149
    [No Abstract]   [Full Text] [Related]  

  • 35. Alterations of 3-nitrotyrosine concentration in the cerebrospinal fluid during aging and in patients with Alzheimer's disease.
    Tohgi H; Abe T; Yamazaki K; Murata T; Ishizaki E; Isobe C
    Neurosci Lett; 1999 Jul; 269(1):52-4. PubMed ID: 10821643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The isolated perfused "working" rat heart: a new method.
    Igić R
    J Pharmacol Toxicol Methods; 1996 Apr; 35(2):63-7. PubMed ID: 8729431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic drift in the aging nervous system is reflected in human cerebrospinal fluid.
    Peters K; Herman S; Khoonsari PE; Burman J; Neumann S; Kultima K
    Sci Rep; 2021 Sep; 11(1):18822. PubMed ID: 34552125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chromogranin A Deficiency Attenuates Tauopathy by Altering Epinephrine-Alpha-Adrenergic Receptor Signaling.
    Mahata S; Jati S; Munoz-Mayorga D; Shahabi S; Tang K; Tao Y; Dickson D; Litvan I; Ghosh G; Chen X
    Res Sq; 2024 Aug; ():. PubMed ID: 39149499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential pulse voltammetry and chronoamperometry as analytical tools for epinephrine detection using a tyrosinase-based electrochemical biosensor.
    Baluta S; Meloni F; Halicka K; Szyszka A; Zucca A; Pilo MI; Cabaj J
    RSC Adv; 2022 Sep; 12(39):25342-25353. PubMed ID: 36199318
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.